21st Dec 2012 11:48
SKYEPHARMA PLC - RESULT OF GENERAL MEETING
LONDON, UK, 21 December 2012 - SkyePharma PLC (LSE: SKP) announces the results of the voting by shareholders at the General Meeting held earlier today. The resolution to approve the SkyePharma PLC Long-Term Incentive Plan 2012 was passed with the requisite majority on a show of hands.
In accordance with Listing Rule 9.6.2, a copy of the resolution passed will shortly be submitted to the National Storage Mechanism and will be available for inspection at www.morningstar.co.uk/uk/NSM
The full text of the resolution passed at the meeting can be found in the Notice of General Meeting, which is available for inspection at www.morningstar.co.uk/uk/NSM and on the Company's website at www.skyepharma.com.
Full details of the proxy voting will be available on our website (www.skyepharma.com) later today.
For further information please contact:
SkyePharma PLC | Peter Grant | +44 20 7881 0524 |
John Murphy | ||
FTI Consulting | Julia Phillips | +44 20 7831 3113 |
Susan Stuart | ||
About SkyePharma PLC
SkyePharma uses its multiple drug delivery technologies and expertise to create pharmaceutical products. The Group receives revenues from 13 approved products in the areas of inhalation, oral, topical and injectable delivery as well as generating income from the development of further products and technology licenses. The Group's products are marketed throughout the world by leading
pharmaceutical companies. For more information, visit www.skyepharma.com.
Related Shares:
SKP.L